PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
GlobeNewswire
Press release
*PEP-Therapy and Institut Curie Announce First Patients Dosed*
*in Phase Ib Clinical Trial Evaluating..